Fair enough, didn't see that. My bad. At least not the CEO or a Director. As I said, hopefully the new guy can turn this mangy dog with fleas around. Won't bet my lunch money on it though.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status